Metraipolis › archive › dc_ba2c36afa78a
4-weekly avelumab plus axitinib in patients with metastatic renal cell carcinoma — Europe PMC PMID:42103905
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42103905
- DOI
- 10.1038/s44276-[numero omesso]-y
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T14:58:47.295Z
- SHA-256 of the archived text
57de92342d5bd3385add9dd57828e6595ad5dabc986ee5b7c303dc797b72179e- Stable URL of this page
https://metraipolis.com/documento/dc_ba2c36afa78a
How to cite
4-weekly avelumab plus axitinib in patients with metastatic renal cell carcinoma — Europe PMC PMID:42103905 — Europe PMC (en), https://europepmc.org/article/MED/42103905 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ba2c36afa78a (Metraipolis archive dc_ba2c36afa78a, sha256 57de92342d5bd3385add9dd57828e6595ad5dabc986ee5b7c303dc797b72179e)
BibTeX
@misc{dcba2c36afa78a,
title = {4-weekly avelumab plus axitinib in patients with metastatic renal cell carcinoma — Europe PMC PMID:42103905},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42103905},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ba2c36afa78a; sha256 57de92342d5bd3385add9dd57828e6595ad5dabc986ee5b7c303dc797b72179e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42103905. Agents can read the archived copy with the MCP tool read_document.